Target intelligence / Profile preview

Alveolar septum

Molecular classification
Other, Anatomical structure, Tissue
01

Overview

The alveolar septum is the thin tissue wall separating adjacent pulmonary alveoli, functioning as the primary site for gas exchange in the respiratory system (StatPearls, 2023). It is structurally composed of an epithelial layer (Type I and Type II pneumocytes), a basement membrane, and an interstitial space containing fibroblasts, collagen fibers, and a dense capillary network (NIH, 2022). This "blood-air barrier" is essential for the diffusion of oxygen into the bloodstream and the removal of carbon dioxide. In various pathologies, the alveolar septum undergoes significant structural changes; for example, its destruction is the hallmark of emphysema, while its thickening due to collagen deposition is characteristic of pulmonary fibrosis (PubMed, 2021). Although the septum itself is an anatomical structure and not a single molecular target, it contains numerous therapeutic targets such as TGF-beta receptors and various ion channels that are modulated by drugs like Nintedanib or Pirfenidone to treat interstitial lung diseases.

Other names
Interalveolar septumAlveolar wallParenchymal septum
02

Mechanism of action

The alveolar septum is an anatomical structure rather than a single molecular target; drugs associated with this region typically act by modulating specific cellular pathways (e.g., inhibiting tyrosine kinases or inflammatory cytokines) within the septal fibroblasts and epithelial cells to prevent remodeling or inflammation (PubMed, 2021).

03

Biological functions

OtherGas exchangeBlood-air barrier formationSurfactant productionStructural support
04

Disease associations

InflammationOtherEmphysemaPulmonary fibrosisAcute respiratory distress syndrome (ARDS)Interstitial lung disease
05

Safety considerations

Septal destruction (emphysema)Septal fibrosisAlveolar-capillary membrane disruption
06

Interacting drugs

Nintedanib

2 more in the full profile.

07

Biomarkers

Septal thickening on high-resolution computed tomography (HRCT)Diffusing capacity of the lungs for carbon monoxide (DLCO)

Beyond the preview

Go deeper on Alveolar septum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alveolar septum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call